Literature DB >> 25031032

Localizing seizure-susceptible brain regions associated with low-grade gliomas using voxel-based lesion-symptom mapping.

Yinyan Wang1, Tianyi Qian1, Gan You1, Xiaoxia Peng1, Clark Chen1, Yongping You1, Kun Yao1, Chenxing Wu1, Jun Ma1, Zhiyi Sha1, Sonya Wang1, Tao Jiang1.   

Abstract

BACKGROUND: Patients afflicted with low-grade glioma (LGG) frequently suffer from seizures. The mechanisms of seizure initiation in these patients remain poorly understood. Tumor location has been correlated with seizure initiation. However, these correlative studies relied on dichotomized data analysis based on arbitrary lobe assignments. As a result, the lesion-symptom correlation may be incorrectly interpreted. Here, we present the first study that used a voxel-wise quantitative lesion analysis to investigate the spatial correlation between tumor location and seizure susceptibility.
METHODS: We collected the medical records and magnetic resonance images of 410 LGG patients. The dataset was divided into a discovery set and a validation set. A voxel-based lesion-symptom correlative analysis was performed to determine whether tumor location was associated with seizure risk and could be related to the specific type of seizure.
RESULTS: For all seizure types, increased seizure risks were identified for LGGs that involved the left premotor area. The LGGs that involved the posterior portion of the left inferior and middle frontal gyrus were associated with increased risk of simple partial seizures. LGGs that involved the right temporal-insular region were associated with an increased risk of complex partial seizures. LGGs that involved the left premotor area were more likely to be associated with seizures that generalize. These correlations were consistently observed in both the discovery and the validation datasets.
CONCLUSIONS: Our quantitative neuroimaging analyses support the concept that the anatomic location of an LGG is a contributing factor in tumor-related seizure.
© The Author(s) 2014. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  lesion-symptom mapping; low-grade glioma; seizure

Mesh:

Year:  2014        PMID: 25031032      PMCID: PMC4288515          DOI: 10.1093/neuonc/nou130

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  29 in total

Review 1.  Low-grade gliomas in adults.

Authors:  Jeanine T Grier; Tracy Batchelor
Journal:  Oncologist       Date:  2006-06

2.  Power in Voxel-based lesion-symptom mapping.

Authors:  Daniel Y Kimberg; H Branch Coslett; Myrna F Schwartz
Journal:  J Cogn Neurosci       Date:  2007-07       Impact factor: 3.225

3.  Intraoperative risk of seizures associated with transient direct cortical stimulation in patients with symptomatic epilepsy.

Authors:  Andrea Szelényi; Boban Joksimovic; Volker Seifert
Journal:  J Clin Neurophysiol       Date:  2007-02       Impact factor: 2.177

4.  Epileptic seizures during follow-up of patients treated for primary brain tumors.

Authors:  Jerzy Hildebrand; Cristel Lecaille; Joëlle Perennes; Jean-Yves Delattre
Journal:  Neurology       Date:  2005-07-26       Impact factor: 9.910

Review 5.  Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management.

Authors:  Melanie S M van Breemen; Erik B Wilms; Charles J Vecht
Journal:  Lancet Neurol       Date:  2007-05       Impact factor: 44.182

6.  Inappropriate usage of the Brunner-Munzel test in recent voxel-based lesion-symptom mapping studies.

Authors:  Jared Medina; Daniel Y Kimberg; Anjan Chatterjee; H Branch Coslett
Journal:  Neuropsychologia       Date:  2010-01       Impact factor: 3.139

7.  The 2007 WHO classification of tumors of the nervous system: controversies in surgical neuropathology.

Authors:  Bernd W Scheithauer; Greg N Fuller; Scott R VandenBerg
Journal:  Brain Pathol       Date:  2008-07       Impact factor: 6.508

8.  Seizure characteristics and control following resection in 332 patients with low-grade gliomas.

Authors:  Edward F Chang; Matthew B Potts; G Evren Keles; Kathleen R Lamborn; Susan M Chang; Nicholas M Barbaro; Mitchel S Berger
Journal:  J Neurosurg       Date:  2008-02       Impact factor: 5.115

9.  Frequency of seizures in patients with newly diagnosed brain tumors: a retrospective review.

Authors:  Laura M Lynam; Mark K Lyons; Joseph F Drazkowski; Joseph I Sirven; Katherine H Noe; Richard S Zimmerman; James A Wilkens
Journal:  Clin Neurol Neurosurg       Date:  2007-06-29       Impact factor: 1.876

Review 10.  The 2007 WHO classification of tumours of the central nervous system.

Authors:  David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues
Journal:  Acta Neuropathol       Date:  2007-07-06       Impact factor: 17.088

View more
  69 in total

Review 1.  Tumor-related epilepsy: epidemiology, pathogenesis and management.

Authors:  Dillon Y Chen; Clark C Chen; John R Crawford; Sonya G Wang
Journal:  J Neurooncol       Date:  2018-05-24       Impact factor: 4.130

2.  Aging-related tumor associated fibroblasts changes could worsen the prognosis of GBM patients.

Authors:  Hongwang Song; Xiaojun Fu; Chenxing Wu; Shouwei Li
Journal:  Cancer Cell Int       Date:  2020-10-08       Impact factor: 5.722

3.  Activation of the mTOR signaling pathway in peritumoral tissues can cause glioma-associated seizures.

Authors:  Yang Yuan; Wang Xiang; Liu Yanhui; Liang Ruofei; Luo Jiewen; Jiang Shu; Mao Qing
Journal:  Neurol Sci       Date:  2016-09-19       Impact factor: 3.307

4.  Age-associated brain regions in gliomas: a volumetric analysis.

Authors:  Yinyan Wang; Shuai Liu; Xing Fan; Shaowu Li; Renzhi Wang; Lei Wang; Jun Ma; Tao Jiang; Wenbin Ma
Journal:  J Neurooncol       Date:  2015-05-16       Impact factor: 4.130

5.  Deficiency of very large G-protein-coupled receptor-1 is a risk factor of tumor-related epilepsy: a whole transcriptome sequencing analysis.

Authors:  Yinyan Wang; Xing Fan; Wei Zhang; Chuanbao Zhang; Jiangfei Wang; Tao Jiang; Lei Wang
Journal:  J Neurooncol       Date:  2014-12-16       Impact factor: 4.130

6.  Multivariate machine learning-based language mapping in glioma patients based on lesion topography.

Authors:  Nan Zhang; Binke Yuan; Jing Yan; Jingliang Cheng; Junfeng Lu; Jinsong Wu
Journal:  Brain Imaging Behav       Date:  2021-02-22       Impact factor: 3.978

7.  Oncogene or tumor suppressor? Long noncoding RNAs role in patient's prognosis varies depending on disease type.

Authors:  Yingbo Huang; Alexander Ling; Siddhika Pareek; R Stephanie Huang
Journal:  Transl Res       Date:  2020-11-02       Impact factor: 7.012

8.  Transcription factor networks of oligodendrogliomas treated with adjuvant radiotherapy or observation inform prognosis.

Authors:  Jonathan So; Yasin Mamatjan; Gelareh Zadeh; Kenneth Aldape; Fabio Y Moraes
Journal:  Neuro Oncol       Date:  2021-05-05       Impact factor: 12.300

9.  Association of IDH mutation and 1p19q co-deletion with tumor immune microenvironment in lower-grade glioma.

Authors:  Wanzun Lin; Xianxin Qiu; Pian Sun; Yuling Ye; Qingting Huang; Lin Kong; Jiade J Lu
Journal:  Mol Ther Oncolytics       Date:  2021-04-29       Impact factor: 7.200

10.  The relationship between PLOD1 expression level and glioma prognosis investigated using public databases.

Authors:  Lei Tian; Huandi Zhou; Guohui Wang; Wen Yan Wang; Yuehong Li; Xiaoying Xue
Journal:  PeerJ       Date:  2021-05-14       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.